...
search icon
neo-img

NeoGenomics Inc Share Price

NEO
NAQ
$11.42
+$0.15
(1.33%)
1D
Industry: Health Care Providers & Services Sector: Health Care

NeoGenomics Inc Analyst Forecast

NeoGenomics Inc Share Price Chart

NeoGenomics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.46B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.41M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.58
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.72 L
$14.73 H
$11.42

About NeoGenomics Inc, Common Stock

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. more

Industry: Health Care Providers & ServicesSector: Health Care

NeoGenomics Inc Stock Returns

Time FrameNEOSectorS&P500
1-Week Return-5.31%0.06%-2.06%
1-Month Return-10.78%-2.06%-2.06%
3-Month Return9.81%6.1%1.11%
6-Month Return108.01%18.64%7.13%
1-Year Return-15.34%5.25%11.74%
3-Year Return-2.73%17.35%65.43%
5-Year Return-79.62%33.7%73.53%
10-Year Return92.26%143.77%266.66%

NeoGenomics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue444.45M484.33M509.73M591.64M660.57M[{"date":"2020-12-31","value":67.28,"profit":true},{"date":"2021-12-31","value":73.32,"profit":true},{"date":"2022-12-31","value":77.17,"profit":true},{"date":"2023-12-31","value":89.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue258.56M297.27M321.83M347.04M370.47M[{"date":"2020-12-31","value":69.79,"profit":true},{"date":"2021-12-31","value":80.24,"profit":true},{"date":"2022-12-31","value":86.87,"profit":true},{"date":"2023-12-31","value":93.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit185.89M187.06M187.90M244.60M290.10M[{"date":"2020-12-31","value":64.08,"profit":true},{"date":"2021-12-31","value":64.48,"profit":true},{"date":"2022-12-31","value":64.77,"profit":true},{"date":"2023-12-31","value":84.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin41.83%38.62%36.86%41.34%43.92%[{"date":"2020-12-31","value":95.24,"profit":true},{"date":"2021-12-31","value":87.94,"profit":true},{"date":"2022-12-31","value":83.94,"profit":true},{"date":"2023-12-31","value":94.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses199.88M305.81M345.52M352.34M382.21M[{"date":"2020-12-31","value":52.3,"profit":true},{"date":"2021-12-31","value":80.01,"profit":true},{"date":"2022-12-31","value":90.4,"profit":true},{"date":"2023-12-31","value":92.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(13.99M)(118.75M)(157.62M)(107.74M)(92.11M)[{"date":"2020-12-31","value":-1399200000,"profit":false},{"date":"2021-12-31","value":-11875400000,"profit":false},{"date":"2022-12-31","value":-15762300000,"profit":false},{"date":"2023-12-31","value":-10773600000,"profit":false},{"date":"2024-12-31","value":-9210600000,"profit":false}]
Total Non-Operating Income/Expense(7.08M)98.60M(3.23M)20.63M23.24M[{"date":"2020-12-31","value":-7.18,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.27,"profit":false},{"date":"2023-12-31","value":20.93,"profit":true},{"date":"2024-12-31","value":23.57,"profit":true}]
Pre-Tax Income(14.06M)(15.07M)(159.34M)(97.10M)(80.67M)[{"date":"2020-12-31","value":-1405600000,"profit":false},{"date":"2021-12-31","value":-1507500000,"profit":false},{"date":"2022-12-31","value":-15934200000,"profit":false},{"date":"2023-12-31","value":-9709700000,"profit":false},{"date":"2024-12-31","value":-8067500000,"profit":false}]
Income Taxes(18.23M)(6.73M)(15.09M)(9.13M)(1.95M)[{"date":"2020-12-31","value":-1822800000,"profit":false},{"date":"2021-12-31","value":-672800000,"profit":false},{"date":"2022-12-31","value":-1509200000,"profit":false},{"date":"2023-12-31","value":-912900000,"profit":false},{"date":"2024-12-31","value":-194900000,"profit":false}]
Income After Taxes4.17M(8.35M)(144.25M)(87.97M)(78.73M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-200.07,"profit":false},{"date":"2022-12-31","value":-3457.57,"profit":false},{"date":"2023-12-31","value":-2108.53,"profit":false},{"date":"2024-12-31","value":-1887.01,"profit":false}]
Income From Continuous Operations4.17M(8.35M)(144.25M)(87.97M)(78.73M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-200.07,"profit":false},{"date":"2022-12-31","value":-3457.57,"profit":false},{"date":"2023-12-31","value":-2108.53,"profit":false},{"date":"2024-12-31","value":-1887.01,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income4.17M(8.35M)(144.25M)(87.97M)(78.73M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-200.07,"profit":false},{"date":"2022-12-31","value":-3457.57,"profit":false},{"date":"2023-12-31","value":-2108.53,"profit":false},{"date":"2024-12-31","value":-1887.01,"profit":false}]
EPS (Diluted)0.14(0.27)(0.56)(0.26)(0.09)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-192.86,"profit":false},{"date":"2022-12-31","value":-400,"profit":false},{"date":"2023-12-31","value":-183.79,"profit":false},{"date":"2024-12-31","value":-63.86,"profit":false}]

NeoGenomics Inc Ratios

NeoGenomics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NEO
Cash Ratio 1.68
Current Ratio 3.91
Quick Ratio 3.62

NeoGenomics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NEO
ROA (LTM) -3.03%
ROE (LTM) -12.99%

NeoGenomics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NEO
Debt Ratio Lower is generally better. Negative is bad. 0.39
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.61

NeoGenomics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NEO
Trailing PE NM
Forward PE 222.22
P/S (TTM) 2.06
P/B 1.85
Price/FCF 2558
EV/R 2.53
EV/Ebitda NM
PEG 3.02

FAQs

What is NeoGenomics Inc share price today?

NeoGenomics Inc (NEO) share price today is $11.42

Can Indians buy NeoGenomics Inc shares?

Yes, Indians can buy shares of NeoGenomics Inc (NEO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NEO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NeoGenomics Inc be purchased?

Yes, you can purchase fractional shares of NeoGenomics Inc (NEO) via the Vested app. You can start investing in NeoGenomics Inc (NEO) with a minimum investment of $1.

How to invest in NeoGenomics Inc shares from India?

You can invest in shares of NeoGenomics Inc (NEO) via Vested in three simple steps:

  • Click on Sign Up or Invest in NEO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NeoGenomics Inc shares
What is NeoGenomics Inc 52-week high and low stock price?

The 52-week high price of NeoGenomics Inc (NEO) is $14.73. The 52-week low price of NeoGenomics Inc (NEO) is $4.72.

What is NeoGenomics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of NeoGenomics Inc (NEO) is

What is NeoGenomics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NeoGenomics Inc (NEO) is 1.85

What is NeoGenomics Inc dividend yield?

The dividend yield of NeoGenomics Inc (NEO) is 0.00%

What is the Market Cap of NeoGenomics Inc?

The market capitalization of NeoGenomics Inc (NEO) is $1.46B

What is NeoGenomics Inc's stock symbol?

The stock symbol (or ticker) of NeoGenomics Inc is NEO

How Can Investors Use NeoGenomics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of NeoGenomics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether NeoGenomics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from NeoGenomics Inc shares for Indian investors?

When investing in NeoGenomics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the NeoGenomics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare NeoGenomics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of NeoGenomics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that NeoGenomics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top